Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Hae-Ock Lee
Affiliation
College of Medicine, The Catholic University of Korea
ORCID
Career Start Year
1996
Papers
54
H Index
23
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36797491
Single-cell mapping of combinatorial target antigens for CAR switches using logic gates.
Nat Biotechnol
2023
37540709
Association of cyclooxygenase-2 expression with endoplasmic reticulum stress and autophagy in triple-negative breast cancer.
PLoS One
2023
36623812
Perspectives on single-nucleus RNA sequencing in different cell types and tissues.
J Pathol Transl Med
2023
36650700
CTLA-4 inhibition facilitates follicular T and B cell interaction and the production of tumor-specific antibodies.
Int J Cancer
2023
35069539
Granulocyte Macrophage-Colony Stimulating Factor Produces a Splenic Subset of Monocyte-Derived Dendritic Cells That Efficiently Polarize T Helper Type 2 Cells in Response to Blood-Borne Antigen.
Front Immunol
2022
35710446
The regulation of insulin receptor/insulin-like growth factor 1 receptor ratio, an important factor for breast cancer prognosis, by TRIP-Br1.
J Hematol Oncol
2022
36397035
Prescreening of tumor samples for tumor-centric transcriptome analyses of lung adenocarcinoma.
BMC Cancer
2022
36333342
2'-5' oligoadenylate synthetaseâ¿¿like 1 (OASL1) protects against atherosclerosis by maintaining endothelial nitric oxide synthase mRNA stability.
Nat Commun
2022
36115863
Single-cell transcriptomics reveal cellular diversity of aortic valve and the immunomodulation by PPARγ during hyperlipidemia.
Nat Commun
2022
33983580
Single Cell Genomics for Tumor Heterogeneity.
Adv Exp Med Biol
2021
34439827
Clinical Perspectives of Single-Cell RNA Sequencing.
Biomolecules
2021
31558476
Alterations in the Transcriptional Programs of Myeloma Cells and the Microenvironment during Extramedullary Progression Affect Proliferation and Immune Evasion.
Clin Cancer Res
2020
33277616
Tumor-promoting macrophages prevail in malignant ascites of advanced gastric cancer.
Exp Mol Med
2020
32661348
Cancer cells undergoing epigenetic transition show short-term resistance and are transformed into cells with medium-term resistance by drug treatment.
Exp Mol Med
2020
32883094
Anti-Inflammatory Actions of Soluble Ninjurin-1 Ameliorate Atherosclerosis.
Circulation
2020
32934030
Correction: Alterations in the Transcriptional Programs of Myeloma Cells and the Microenvironment during Extramedullary Progression Affect Proliferation and Immune Evasion.
Clin Cancer Res
2020
32385277
Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma.
Nat Commun
2020
32460812
Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient.
Genome Med
2020
32451460
Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer.
Nat Genet
2020
31100099
Alternative polyadenylation of single cells delineates cell types and serves as a prognostic marker in early stage breast cancer.
PLoS One
2019
29208629
SIDR: simultaneous isolation and parallel sequencing of genomic DNA and total RNA from single cells.
Genome Res
2018
29898899
Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data.
Genome Res
2018
27409339
Nonlinear tumor evolution from dysplastic nodules to hepatocellular carcinoma.
Oncotarget
2017
28474673
Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer.
Nat Commun
2017
28263318
Spatiotemporal genomic architecture informs precision oncology in glioblastoma.
Nat Genet
2017
28939741
Tumor Heterogeneity Predicts Metastatic Potential in Colorectal Cancer.
Clin Cancer Res
2017
28985013
HDAC2/3 binding and deacetylation of BubR1 initiates spindle assembly checkpoint silencing.
FEBS J
2017
28539161
Single-cell RNA-Seq unveils tumor microenvironment.
BMB Rep
2017
27223072
Comprehensive genomic profiling of IgM multiple myeloma identifies IRF4 as a prognostic marker.
Oncotarget
2016
27634910
Recurrent mutations of MAPK pathway genes in multiple myeloma but not in amyloid light-chain amyloidosis.
Oncotarget
2016
27139883
Application of single-cell RNA sequencing in optimizing a combinatorial therapeutic strategy in metastatic renal cell carcinoma.
Genome Biol
2016
25527510
Standard immunohistochemistry efficiently screens for anaplastic lymphoma kinase rearrangements in differentiated thyroid cancer.
Endocr Relat Cancer
2015
26305796
Identification of Distinct Tumor Subpopulations in Lung Adenocarcinoma via Single-Cell RNA-seq.
PLoS One
2015
26265110
The use of FNA samples for whole-exome sequencing and detection of somatic mutations in breast cancer surgical specimens.
Cancer Cytopathol
2015
26155838
The diagnostic application of targeted re-sequencing in Korean patients with retinitis pigmentosa.
BMC Genomics
2015
26084335
Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells.
Genome Biol
2015
26023078
Deregulation of Retinaldehyde Dehydrogenase 2 Leads to Defective Angiogenic Function of Endothelial Colony-Forming Cells in Pediatric Moyamoya Disease.
Arterioscler Thromb Vasc Biol
2015
25666348
Brca2 deficiency leads to T cell loss and immune dysfunction.
Mol Cells
2015
23878276
Loss of BubR1 acetylation causes defects in spindle assembly checkpoint signaling and promotes tumor formation.
J Cell Biol
2013
22340495
BRCA2 fine-tunes the spindle assembly checkpoint through reinforcement of BubR1 acetylation.
Dev Cell
2012
22575646
Cell density-dependent acetylation of οNp63α is associated with p53-dependent cell cycle arrest.
FEBS Lett
2012
20396962
Fgfbp1 is essential for the cellular survival during zebrafish embryogenesis.
Mol Cells
2010
20553902
Inhibition of Plk1 induces mitotic infidelity and embryonic growth defects in developing zebrafish embryos.
Dev Biol
2010
19158078
Control of rapsyn stability by the CUL-3-containing E3 ligase complex.
J Biol Chem
2009
18023281
SuPr-1-mediated desumoylation regulates the repressor activity of DeltaNp63alpha.
FEBS Lett
2007
18028447
Regulation of DeltaNp63alpha by tumor necrosis factor-alpha in epithelial homeostasis.
FEBS J
2007
16616891
A dominant negative form of p63 inhibits apoptosis in a p53-independent manner.
Biochem Biophys Res Commun
2006
12787569
Biology of FasL.
Cytokine Growth Factor Rev
2003
12885868
P-selectin and P-selectin glycoprotein ligand 1 are major determinants for Th1 cell recruitment to nonlymphoid effector sites in the intestinal lamina propria.
J Exp Med
2003
11937536
The state of CD4+ T cell activation is a major factor for determining the kinetics and location of T cell responses to oral antigen.
J Immunol
2002
1 - 50 of 54
Column Actions
Search
Recommended Authors
Tuo Zhang
Weill Cornell Medical College.
Career Start Year
2013
Number of shared co-authors
0
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year
2010
Number of shared co-authors
0
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year
2009
Number of shared co-authors
3
Xinmin Li
University of California los angeles
Career Start Year
2008
Number of shared co-authors
0
Kris Ylaya
Center for Cancer Research, National Cancer Institute
Career Start Year
2008
Number of shared co-authors
1
Linghua Wang
The University of Texas M. D. Anderson
Career Start Year
2006
Number of shared co-authors
0
Maggie Cam
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
2005
Number of shared co-authors
0
Christopher A Bristow
The University of Texas MD Anderson Cancer Center
Career Start Year
2005
Number of shared co-authors
4
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year
2004
Number of shared co-authors
0
Martin Enge
Karolinska Institutet
Career Start Year
2004
Number of shared co-authors
0
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
4
Andrew V Kossenkov
The Wistar Institute
Career Start Year
2003
Number of shared co-authors
0
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year
2003
Number of shared co-authors
0
Donghui Cheng
University of California los angeles
Career Start Year
2003
Number of shared co-authors
0
Michael Slifker
Fox Chase Cancer Center
Career Start Year
2002
Number of shared co-authors
0
Yuelin J Zhu
National Cancer Institute, National Institutes of Health
Career Start Year
2002
Number of shared co-authors
0
Wenyan Zhong
Oncology R&D
Career Start Year
2000
Number of shared co-authors
0
Andrew J Gentles
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year
1999
Number of shared co-authors
0
Jianjun Shen
The University of Texas MD Anderson Cancer Center
Career Start Year
1998
Number of shared co-authors
1
Yaoqi Alan Wang
The University of Texas MD Anderson Cancer Center
Career Start Year
1997
Number of shared co-authors
0
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year
1997
Number of shared co-authors
0
Dongquan Chen
University of Alabama at Birmingham
Career Start Year
1997
Number of shared co-authors
2
Lianbo Yu
The Ohio State University
Career Start Year
1997
Number of shared co-authors
0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year
1996
Number of shared co-authors
0
Timothy A Chan
Cleveland Clinic.
Career Start Year
1994
Number of shared co-authors
3
Jan Paul Medema
Oncode Institute
Career Start Year
1993
Number of shared co-authors
0
Phillip Buckhaults
University of South Carolina
Career Start Year
1993
Number of shared co-authors
0
Wenbin Wei
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield
Career Start Year
1991
Number of shared co-authors
0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year
1988
Number of shared co-authors
4
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Career Start Year
1988
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Co-authored papers
28
Nayoung K D Kim
Samsung Genome Institute, Samsung Medical Center
Co-authored papers
9
Kyu-Tae Kim
Ajou University
Co-authored papers
6
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers
4
Kyeung Min Joo
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers
3
Hye Won Lee
Yonsei University College of Medicine, Severance Hospital
Co-authored papers
3
Joon Seol Bae
Research Institute of Future Medicine, Samsung Medical Center
Co-authored papers
3
Jung-Il Lee
Gangnam Severance Hospital
Co-authored papers
2
Sang Shin
Feinberg School of Medicine, Northwestern University
Co-authored papers
2
Sung Tae Kim
Busan Paik Hospital, Inje University
Co-authored papers
2
Byong Chang Jeong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
2
Jeong Eon Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
2
Yun Jee Seo
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers
2
Soohyun Lee
Co-authored papers
1
Seung Won Choi
Samsung Medical Center, Sungkyunkwan University
Co-authored papers
1
Seung-Ki Kim
Seoul National University Children's Hospital
Co-authored papers
1
Antonio Iavarone
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers
1
In-Hee Lee
Co-authored papers
1
Pablo G Camara
Perelman School of Medicine, University of Pennsylvania
Co-authored papers
1
Andrew X Chen
Columbia University
Co-authored papers
1
Junhyung Kim
Keimyung University School of Medicine
Co-authored papers
1
Daniel I S Rosenbloom
Merck & Co. Inc.
Co-authored papers
1
Ho Jun Seol
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
1
Patrick van Nieuwenhuizen
Columbia University
Co-authored papers
1
Shyam Prabhakar
Genome Institute of Singapore (GIS)
Co-authored papers
1
Peter J Park
Harvard Medical School
Co-authored papers
1
Jeong-Won Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
1
Jin-Ku Lee
Seoul National University, College of Medicine
Co-authored papers
1
Sang Won Jung
Institute for Refractory Cancer Research
Co-authored papers
1
Yeon-Lim Suh
Samsung Medical Center, Sungkyunkwan University College of Medicine
Co-authored papers
1
1 - 30